semaglutide neurological side effects How long after taking do you feel Ozempic: Semaglutide is a GLP-1

Clinical scenarios warranting consideration of GLP-1 therapy include: Type 2 diabetes management : Per ADA 2024 Standards of Care, GLP-1 RAs may be considered as initial therapy in patients with established atherosclerotic cardiovascular disease (ASCVD), high ASCVD risk, chronic kidney disease (CKD), or heart failure, or as add-on therapy when glycemic targets aren't met Established cardiovascular disease : Several GLP-1 receptor agonists have demonstrated cardiovascular risk reduction in patients with type 2 diabetes and established ASCVD Chronic kidney disease : While SGLT2 inhibitors are generally prioritized for CKD with type 2 diabetes when eGFR allows, GLP-1 RAs may provide complementary benefits Obesity with complications : When lifestyle interventions produce insufficient weight loss in patients with obesity-related comorbidities Important safety considerations include: Contraindications : Personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2

Glucagon-like peptide: A oitent regulator of food intake in humans

didnt rule out the possibility that Medicare and Medicaid might cover GLP-1s for obesity treatment in the future as costs come down

Do not use the injection if it has been frozen

Avoid injecting into areas that are tender, red, bruised, hard, or have scars

doi: 10.1210/jc.2014-1250